Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.

Hassan, Marwa; Nasr, Sami Mohamed; Elzallat, Mohamed

Hassan, Marwa; Nasr, Sami Mohamed; Elzallat, Mohamed.

Hassan M; Immunology Department, Theodor Bilharz Research Institute, Warraq El-Hadar, Giza 12411, Egypt. Electronic address: marwahassan_777@yahoo.com.
Nasr SM; Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt.
Elzallat M; Immunology Department, Theodor Bilharz Research Institute, Warraq El-Hadar, Giza 12411, Egypt.

Virus Res ; 312: 198714, 2022 04 15.

Article en En | MEDLINE | ID: mdl-35181408

Asunto(s)

Antígeno AC133/genética; Carcinoma Hepatocelular; Hepatitis C; Hepatitis Viral Humana; Neoplasias Hepáticas; Carcinoma Hepatocelular/genética; Estudios de Casos y Controles; Predisposición Genética a la Enfermedad; Genotipo; Humanos; Cirrosis Hepática/genética; Neoplasias Hepáticas/genética; Polimorfismo de Nucleótido Simple

Palabras clave

CD133; Cancer stem cell (CSC); Hepatitis virus; Hepatocellular carcinoma (HCC); Liver cirrhosis; Single nucleotide polymorphism (SNP)

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis C / Carcinoma Hepatocelular / Antígeno AC133 / Hepatitis Viral Humana / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google